IOL Chemicals rises on European regulator's clearance for API product
** IOL Chemicals IOLC.NS rises 2.1% to 73.35 rupees; set to gain after three straight sessions of losses ** Europe's drug-quality regulator grants chemicals maker Certificate of Suitability for API product "CLOPIDOGREL BESILATE" ** Clopidogrel is an anti-platelet medication used to treat, prevent cardiovascular diseases ** YTD, IOLC down 12% (Reporting by Yagnoseni Das in Bengaluru) ((Yagnoseni.Das@thomsonreuters.com;))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees